We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$91.9B
AUM Growth
-$622M
Cap. Flow
-$6.3B
Cap. Flow %
-6.85%
Top 10 Hldgs %
34.23%
Holding
7,315
New
572
Increased
2,784
Reduced
3,105
Closed
393

Sector Composition

Rank Sector Weight
1 Technology 5.74%
2 Healthcare 5.25%
3 Financials 4.26%
4 Communication Services 3.9%
5 Consumer Discretionary 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
P
5501
Everpure Inc
P
$25.7B
$31K ﹤0.01%
3,118
-25,990
-89% -$288K
RGP icon
5502
Resources Connection
RGP
$151M
$31K ﹤0.01%
1,857
+1,239
+200% +$20.9K
TILE icon
5503
Interface
TILE
$1.99B
$31K ﹤0.01%
1,641
-18,778
-92% -$347K
TPL icon
5504
Texas Pacific Land
TPL
$27.8B
$31K ﹤0.01%
1,008
UGL icon
5505
CALL
ProShares Ultra Gold
UGL
$650M
$31K ﹤0.01%
3,200
-800
-20% -$7.41K
VIRT icon
5506
Virtu Financial
VIRT
$5.11B
$31K ﹤0.01%
1,844
-5,311
-74% -$91.9K
WKHS icon
5507
Workhorse Group
WKHS
$33.2M
$31K ﹤0.01%
+4
New +$41.6K
NAGE
5508
Niagen Bioscience
NAGE
$271M
$31K ﹤0.01%
11,817
+11,293
+2,155% +$32K
JNCE
5509
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$31K ﹤0.01%
+1,400
New +$29.7K
SIOX
5510
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$31K ﹤0.01%
255
-437
-63% -$45.8K
MXWL
5511
CALL
DELISTED
Maxwell Technologies Inc
MXWL
$31K ﹤0.01%
5,300
+1,900
+56% +$9.76K
CYTR
5512
DELISTED
CytRx Corp
CYTR
$31K ﹤0.01%
11,690
+11,386
+3,745% +$28.8K
ARWR icon
5513
CALL
Arrowhead Research
ARWR
$11.9B
$30K ﹤0.01%
16,300
+6,300
+63% +$12.5K
AXSM icon
5514
Axsome Therapeutics
AXSM
$11.2B
$30K ﹤0.01%
7,857
+7,718
+5,553% +$36.9K
CEF icon
5515
Sprott Physical Gold and Silver Trust
CEF
$7.4B
$30K ﹤0.01%
2,300
FRME icon
5516
First Merchants
FRME
$2.68B
$30K ﹤0.01%
767
-542
-41% -$21.1K
GFF icon
5517
Griffon
GFF
$3.95B
$30K ﹤0.01%
1,233
-663
-35% -$16.5K
LNN icon
5518
Lindsay Corp
LNN
$1.13B
$30K ﹤0.01%
348
-3,259
-90% -$255K
MCHI icon
5519
iShares MSCI China ETF
MCHI
$6.32B
$30K ﹤0.01%
597
MERC icon
5520
Mercer International
MERC
$42.3M
$30K ﹤0.01%
2,675
+2,040
+321% +$24K
SAFE
5521
PUT
Safehold
SAFE
$1.16B
$30K ﹤0.01%
+514
New +$29.5K
TMF icon
5522
Direxion Daily 20+ Year Treasury Bull 3X ETF
TMF
$2.16B
$30K ﹤0.01%
+159
New +$29.3K
YUMC icon
5523
CALL
Yum China
YUMC
$16.5B
$30K ﹤0.01%
1,100
-8,300
-88% -$222K
PQ
5524
DELISTED
Petroquest Energy Inc Wd
PQ
$30K ﹤0.01%
10,944
AQB icon
5525
AquaBounty Technologies
AQB
$4.66M
$29K ﹤0.01%
+133
New +$37.3K

Similar funds

Barclays's Q1 2017 Portfolio in Review

As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Barclays withdrew a net $6.3B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.

  • Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
  • Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
  • Barclays's biggest Q1 2017 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $380M.
  • Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
  • Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
  • Barclays opened 572 new positions and closed 393 in Q1 2017.
  • Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.

Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.